P410 Vedolizumab is safe and effective for IBD, but has no effect on liver biochemistry in patients with concurrent PSC.
暂无分享,去创建一个
D. Rubin | P. Gibson | B. Christensen | J. Pekow | D. Micic | V. Rao | A. Yarur | J. Gaetano | J. Kinnucan | E. Bellaguarda | P. Corsello | S. Reddy | S. Singh